Artivion, Inc.

NYSE:AORT

Medical - Devices

Healthcare
$18.54 -0.52%

-$0.11 today

Market cap
$904.56M
Beta
1.26
P/E (TTM)
86.7
EPS (TTM)
$0.24
52W Low $19.16High $48.25

Volume 0.91M

Average 0.64M

AORT Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Artivion, Inc.NYSE: AORT

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $44.8M rose 26.6% year over year, ahead of the +20.8% change in trailing-twelve-month cost of revenue. Sequentially, it fell 3.3% from the prior quarter. Over 3 fiscal years it compounded at +15.4% a year.

Context

  • Cost of revenue amounted to 38.7% of revenue in FY2025, up 2.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +26.6% holds above the trailing-twelve-month pace of +20.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$44.8M-3.3% QoQ
Last fiscal yearDec 2025
$170.88M+22.3% YoY
LTMMar 2026
$169.99M+20.8% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.6%——
1 year+22.3%——
3-year CAGR+15.4%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
170.88M USD
Year-over-year change
+22.3%
4-year CAGR
+14.0%

Cost of Revenue vs competitors

How AORT compares with its peers on the latest reported figures

  • AORT's LTM Mar 2026 cost of revenue of $169.99M is the 6th highest of the 11 companies compared; the peer median is $561.65M.
  • Its year-over-year change of +20.8% is the 6th highest of 11, against a peer median of +23.4%.
  • Cost of revenue amounts to 37.1% of revenue for AORT, versus a peer median of 51.6%.
AORT Competitors Peer median
Cost of Revenue for AORT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARDTArdent Health Partners, LLCLTM Mar 2026$3.23B +127.0%-45.4%50.3%
BKDBrookdale Senior Living Inc.LTM Sep 2026$2.52B +11.2%+3.6%85.5%
ITGRInteger Holdings CorporationLTM Jul 2026$1.4B +4.6%+13.0%76.3%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$1.05B +18.5%+15.7%66.4%
ADUSAddus HomeCare CorporationLTM Jun 2026$998.65M +16.3%+13.8%67.6%
AORTArtivion, Inc.LTM Mar 2026$169.99M +20.8%+15.4%37.1%
INSPInspire Medical Systems, Inc.LTM Jun 2026$124.64M -6.8%+26.3%13.9%
PRCTPROCEPT BioRobotics CorporationLTM Mar 2026$119.22M +28.3%+43.4%37.0%
LQDALiquidia CorporationLTM Jun 2026$33.93M +492.3%+66.7%7.5%
SSIISS Innovations International, Inc.LTM Mar 2026$25M +102.6%+187.2%51.6%
COGTCogent Biosciences, Inc.LTM Jun 2026$2.33M +101.6%——
Peer median (excluding AORT) $561.65M+23.4%+15.7%51.6%

Competitors are the stored peer set for AORT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue298.84M313.79M354M388.54M441.33M
Cost of Revenue101.32M111.27M124.83M139.76M170.88M
Gross Profit197.51M202.52M229.18M248.78M270.45M
Gross Margin66.1%64.5%64.7%64.0%61.3%
Research & Development35.55M38.88M28.71M28.45M30.99M
Selling, General & Admin169.77M157.44M208.98M192.38M212.72M
Operating Expenses189.4M196.32M223.43M209.91M243.71M
Depreciation & Amortization23.98M22.44M23.08M24.21M22.46M
EBITDA26.04M25.68M26.79M50.97M63.82M
EBITDA Margin8.7%8.2%7.6%13.1%14.5%
Operating Income8.12M6.2M5.74M38.87M26.75M
Operating Margin2.7%2.0%1.6%10.0%6.1%
Interest Income79K147K1.08M1.47M763K
Interest Expense16.89M18.22M25.3M34.28M26.58M
Other Income / Expenses(22.94M)(21.19M)(27.33M)(46.39M)(11.97M)
Income Before Tax(14.83M)(14.98M)(21.59M)(7.51M)14.78M
Pre-Tax Margin-5.0%-4.8%-6.1%-1.9%3.3%
Income Tax Expense7K4.21M9.1M5.85M5.01M
Net Income(14.83M)(19.19M)(30.69M)(13.36M)9.77M
Net Margin-5.0%-6.1%-8.7%-3.4%2.2%
EPS (Basic)(0.38)(0.48)(0.75)(0.32)0.22
EPS (Diluted)(0.38)(0.48)(0.75)(0.32)0.21
Weighted Avg Shares38.98M40.03M40.74M41.68M45.34M
Weighted Avg Shares (Diluted)38.98M40.03M40.74M41.68M47.16M

Artivion, Inc.

NYSE:AORT

Intrinsic Alpha fair value

Locked

Current Price

$18.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.